Core Insights - Aegon reported strong progress in business transformation during Q3 2025, with notable growth in its largest segment, Transamerica, particularly in life and annuity sales [2][3] - The company is on track to meet its full-year operating capital generation (OCG) target of EUR 1.2 billion for 2025, with a reported OCG of EUR 340 million before holding funding and operating expenses [3][7] - Aegon plans to provide updates on its strategy and financial targets during the upcoming Capital Markets Day on December 10, 2025, including a review of a potential relocation of its legal domicile and head office to the United States [3][7] Business Performance - Transamerica's distribution network continued to expand, contributing to strong commercial momentum, with individual life sales increasing by 39% compared to the previous year [7] - Despite some outflows in the UK due to the departure of two large, low-margin schemes, Aegon's Asset Management and International businesses showed continued growth [2][7] - The company maintained strong capital ratios across its main units, with cash capital at holding reported at EUR 1.9 billion, reflecting recent share sales and dividend payments [7] Market Position and Strategy - Aegon operates a diverse portfolio, including fully owned businesses in the US and UK, and engages in strategic partnerships in various international markets [8][9] - The company emphasizes its commitment to addressing critical environmental and societal issues as part of its corporate purpose [9] - Aegon's ongoing share buyback program is 54% complete, indicating a proactive approach to capital management [7]

Core Insights - Aegon reported strong commercial momentum in key markets during the first half of 2025, with notable increases in new life sales and net deposits across various regions [5][6][9] - The company is on track to meet its Operating Capital Generation (OCG) guidance for 2025, with a significant operating result and a robust capital position [6][7][9] - Aegon announced a review for relocating its legal domicile and head office to the United States, reflecting its strategic focus on the U.S. market, which constitutes approximately 70% of its operations [8][10] Financial Highlights - New life sales in the U.S. increased by 13% to USD 276 million [5] - The operating result for the first half of 2025 was EUR 845 million, a 19% increase compared to the same period in 2024 [6][9] - Net profit reached EUR 606 million, a significant recovery from a net loss of EUR 65 million in the first half of 2024 [9] Capital Highlights - Aegon reported EUR 576 million in Operating Capital Generation (OCG) for the first half of 2025, maintaining its guidance of around EUR 1.2 billion for the year [6][9] - The company announced an interim dividend of EUR 0.19 per common share, reflecting a year-on-year increase of 19% [7][9] - Aegon is increasing its share buyback program to EUR 400 million, up from the previously announced EUR 200 million [7][9] Strategic Developments - Aegon is conducting a review on the potential relocation of its head office to the U.S., aiming to simplify its corporate structure and align its legal domicile with its primary market [8][10] - The review's outcome is expected to be shared at the Capital Markets Day on December 10, 2025 [10]